Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 12th:
Itron, Inc. (ITRI - Free Report) : This technology and service company that provides end-to-end solutions that measures, manages, and analyzes energy and water use has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.6% over the last 60 days.
Itron’s shares gained 5.8% over the last one month above the S&P 500’s increase 4.1%. The company possesses a Momentum Score of A.
ePlus, Inc. (PLUS - Free Report) : This company that provides information technology solutions that enable organizations to optimize their information technology environment and supply chain processes has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.2% over the last 60 days.
ePlus’ shares gained 17.6% over the last one month. The company possesses a Momentum Score of A.
Guardant Health, Inc. (GH - Free Report) : This precision oncology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 30.7% over the last 60 days.
Guardant Health’s shares gained 13.7% over the last one month. The company possesses a Momentum Score of A.
Genesis Healthcare, Inc. (GEN - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 13% over the last 60 days.
Genesis Healthcare’s shares gained 19.8% over the last one month. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 12th:
Itron, Inc. (ITRI - Free Report) : This technology and service company that provides end-to-end solutions that measures, manages, and analyzes energy and water use has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.6% over the last 60 days.
Itron’s shares gained 5.8% over the last one month above the S&P 500’s increase 4.1%. The company possesses a Momentum Score of A.
ePlus, Inc. (PLUS - Free Report) : This company that provides information technology solutions that enable organizations to optimize their information technology environment and supply chain processes has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.2% over the last 60 days.
ePlus’ shares gained 17.6% over the last one month. The company possesses a Momentum Score of A.
Guardant Health, Inc. (GH - Free Report) : This precision oncology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 30.7% over the last 60 days.
Guardant Health’s shares gained 13.7% over the last one month. The company possesses a Momentum Score of A.
Genesis Healthcare, Inc. (GEN - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 13% over the last 60 days.
Genesis Healthcare’s shares gained 19.8% over the last one month. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on ITRI - FREE
Get the latest research report on GEN - FREE
Get the latest research report on PLUS - FREE
Get the latest research report on GH - FREE